If you made any changes in Pure these will be visible here soon.

Personal profile

Education

  • 2011 國立交通大學生物資訊及系統生物研究所博士
  • 2007 國立交通大學生物資訊研究所碩士
  • 2005 國立交通大學生物科技學系學士

Experience

  • 2019- 臺北醫學大學癌症生物學與藥物研發研究所副教授
  • 2019- 臺北醫學大學生技醫療產業研發博士學位學程副教授
  • 2018- 臺北醫學大學癌症生物學與藥物研發研究所助理教授
  • 2015- 臺北醫學大學癌症生物學與藥物研發博士學位學程助理教授
  • 2013-2015 國立交通大學約聘助理研究員
  • 2011-2013 國立交通大學博士後研究員

Research Interests

  • 生物學之生化及分子生物
  • 生物資訊與醫療資訊

Fingerprint Dive into the research topics where Kai-Cheng Hsu is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 4 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects

電腦輔助設計與研發新穎DYRK1B抑制劑

Hsu, K.

1/1/2012/31/20

Project: A - Government Institutiond - Ministry of Education

Design and Potency Optimization of Kinase Inhibitors for Cancer Treatment(1/3)

Hsu, K.

8/1/197/31/20

Project: A - Government Institutionb - Ministry of Science and Technology

Integrated Bioinformatics Approaches to Study the Mechanisms and Discover Drugs of Hcv-Induced Type 2 Diabetes Mellitus(3/3)

Hsu, K.

8/1/197/31/20

Project: A - Government Institutionb - Ministry of Science and Technology

Discovery and Design of Kinase Inhibitors for Cancer Treatment

Hsu, K.

8/1/187/1/19

Project: A - Government Institutionb - Ministry of Science and Technology

Discovery of Selective Inhibitors for Oncoprotein Kinases

Hsu, K.

8/1/177/31/18

Project: A - Government Institutionb - Ministry of Science and Technology

Research Output

  • 629 Citations
  • 14 h-Index
  • 51 Article
  • 4 Review article
  • 3 Conference contribution
  • 1 Comment/debate

A site-moiety map and virtual screening approach for discovery of novel 5-LOX inhibitors

Hsu, K. C., HuangFu, W. C., Lin, T. E., Chao, M. W., Sung, T. Y., Chen, Y. Y., Pan, S. L., Lee, J. C., Tzou, S. C., Sun, C. M. & Yang, J. M., Dec 1 2020, In : Scientific Reports. 10, 1, 10510.

Research output: Contribution to journalArticle

Open Access
  • Fluoropyrimidin-2,4-dihydroxy-5-isopropylbenzamides as antitumor agents against CRC and NSCLC cancer cells

    Wu, W. C., Liu, Y. M., Liao, Y. H., Hsu, K. C., Lien, S. T., Chen, I. C., Lai, M. J., Li, Y. H., Pan, S. L., Chen, M. C. & Liou, J. P., Oct 1 2020, In : European Journal of Medicinal Chemistry. 203, 112540.

    Research output: Contribution to journalArticle

  • Functional analysis of Clostridium difficile sortase B reveals key residues for catalytic activity and substrate specificity

    Kang, C. Y., Huang, I. H., Chou, C. C., Wu, T. Y., Chang, J. C., Hsiao, Y. Y., Cheng, C. H., Tsai, W. J., Hsu, K. C. & Wang, S., Mar 13 2020, In : Journal of Biological Chemistry. 295, 11, p. 3734-3745 12 p.

    Research output: Contribution to journalArticle

  • Open Access